These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Organ changes induced by ergot derivative dopamine agonist drugs: time to change treatment guidelines in Parkinson's disease?]. Roth J; Ulmanová O; Růzicka E Cas Lek Cesk; 2005; 144(2):123-6. PubMed ID: 15807300 [TBL] [Abstract][Full Text] [Related]
12. [Retroperitoneal fibrosis secondary to treatment with L-dopa analogues for Parkinson disease]. Sánchez-Chapado M; Angulo Cuesta J; Guil Cid M; Jiménez FJ; López Alvarez YJ Arch Esp Urol; 1995 Dec; 48(10):979-83. PubMed ID: 8588730 [TBL] [Abstract][Full Text] [Related]
13. Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease. Tintner R; Manian P; Gauthier P; Jankovic J Arch Neurol; 2005 Aug; 62(8):1290-5. PubMed ID: 16087771 [TBL] [Abstract][Full Text] [Related]
14. Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis. Corvol JC; Anzouan-Kacou JB; Fauveau E; Bonnet AM; Lebrun-Vignes B; Girault C; Agid Y; Lechat P; Isnard R; Lacomblez L Arch Neurol; 2007 Dec; 64(12):1721-6. PubMed ID: 18071034 [TBL] [Abstract][Full Text] [Related]
15. [Multiple latency test in a patient with episodes of sleep induced by pergolide]. Jiménez-Jiménez FJ; Velasco I; de Toledo M; Sayed Y; Zurdo J; Ortí-Pareja M Rev Neurol; 2002 Jun 16-30; 34(12):1140-1. PubMed ID: 12134281 [TBL] [Abstract][Full Text] [Related]
16. Refractory generalized edema: an infrequent complication of long-term pergolide treatment for Parkinson disease. Bianchi M; Castiglioni MG Clin Neuropharmacol; 2005; 28(5):245-6. PubMed ID: 16239767 [TBL] [Abstract][Full Text] [Related]
17. [Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide]. van Laar T; Berendse H; Bloem BR; Boon AJ; van Hilten JJ; Hovestadt A; de Koning-Tijssen MA; Nijssen PC; Weber WE Ned Tijdschr Geneeskd; 2009 Jan; 153(3):87-90. PubMed ID: 19235345 [No Abstract] [Full Text] [Related]
18. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias. Storch A; Trenkwalder C; Oehlwein C; Winkelmann J; Polzer U; Hundemer HP; Schwarz J Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640 [TBL] [Abstract][Full Text] [Related]
19. Retroperitoneal fibrosis caused by treatment with pergolide in a patient with Parkinson's disease. Kunkler RB; Osborn DE; Abbott RJ Br J Urol; 1998 Jul; 82(1):147. PubMed ID: 9698685 [No Abstract] [Full Text] [Related]
20. [Sleep attacks and pergolide mesylate]. García Ruiz PJ; Hernández J; Cantarero S; Fanjul S Neurologia; 2001 Feb; 16(2):92. PubMed ID: 11257938 [No Abstract] [Full Text] [Related] [Next] [New Search]